Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Nox4 reprograms cardiac substrate metabolism via protein O-GlcNAcylation to enhance stress adaptation
Adam A. Nabeebaccus, Anna Zoccarato, Anne D. Hafstad, Celio X.C. Santos, Ellen Aasum, Alison C. Brewer, Min Zhang, Matteo Beretta, Xiaoke Yin, James A. West, Katrin Schröder, Julian L. Griffin, Thomas R. Eykyn, E. Dale Abel, Manuel Mayr, Ajay M. Shah
Adam A. Nabeebaccus, Anna Zoccarato, Anne D. Hafstad, Celio X.C. Santos, Ellen Aasum, Alison C. Brewer, Min Zhang, Matteo Beretta, Xiaoke Yin, James A. West, Katrin Schröder, Julian L. Griffin, Thomas R. Eykyn, E. Dale Abel, Manuel Mayr, Ajay M. Shah
View: Text | PDF
Research Article Cardiology Metabolism

Nox4 reprograms cardiac substrate metabolism via protein O-GlcNAcylation to enhance stress adaptation

  • Text
  • PDF
Abstract

Cardiac hypertrophic remodeling during chronic hemodynamic stress is associated with a switch in preferred energy substrate from fatty acids to glucose, usually considered to be energetically favorable. The mechanistic interrelationship between altered energy metabolism, remodeling, and function remains unclear. The ROS-generating NADPH oxidase-4 (Nox4) is upregulated in the overloaded heart, where it ameliorates adverse remodeling. Here, we show that Nox4 redirects glucose metabolism away from oxidation but increases fatty acid oxidation, thereby maintaining cardiac energetics during acute or chronic stresses. The changes in glucose and fatty acid metabolism are interlinked via a Nox4-ATF4–dependent increase in the hexosamine biosynthetic pathway, which mediates the attachment of O-linked N-acetylglucosamine (O-GlcNAcylation) to the fatty acid transporter CD36 and enhances fatty acid utilization. These data uncover a potentially novel redox pathway that regulates protein O-GlcNAcylation and reprograms cardiac substrate metabolism to favorably modify adaptation to chronic stress. Our results also suggest that increased fatty acid oxidation in the chronically stressed heart may be beneficial.

Authors

Adam A. Nabeebaccus, Anna Zoccarato, Anne D. Hafstad, Celio X.C. Santos, Ellen Aasum, Alison C. Brewer, Min Zhang, Matteo Beretta, Xiaoke Yin, James A. West, Katrin Schröder, Julian L. Griffin, Thomas R. Eykyn, E. Dale Abel, Manuel Mayr, Ajay M. Shah

×

Figure 1

Nox4 alters the levels of cardiac proteins involved in glycolysis and fatty acid oxidation.

Options: View larger image (or click on image) Download as PowerPoint
Nox4 alters the levels of cardiac proteins involved in glycolysis and fa...
(A) Categorization of differentially expressed proteins in Nox4 TG hearts by biological function, according to gene ontology. Difference in-gel electrophoresis (DIGE) was used to determine differentially expressed protein spots from WT and Nox4 TG hearts, followed by mass spectrometry to identify the proteins. (B) Immunoblotting for proteins involved in glycolysis and fatty acid β-oxidation. Representative immunoblots are shown to the left. Relative change in levels compared with WT hearts are shown to the right. *P < 0.05, 2-tailed t test (n = 3–4). See Supplemental Figure 1C for full names of the proteins. (C) mRNA expression levels of the proteins shown in C, expressed as fold-change compared with WT. *P < 0.05, 2-tailed t test (n = 3–6 per group).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts